Part AOutcome blind

Serial Acquirer Economics And Governance · Decision packet

TransDigm acquisition-compounding and funding-resilience re-underwriting decision

After TransDigm's Q1 FY2015 filing and the signed Telair agreement were public, should a public-equity underwriting committee initiate, add, maintain, defer, reduce or avoid exposure, and which product, organic-growth, acquisition-return, accounting, funding, governance and valuation gates must clear first?

Knowledge cutoffFebruary 25, 2015 at 11:59 PM

Executive summary

  • Decision: initiate or add no capital, and authorize no trade. If a human-approved, mandate-compliant position already exists, maintain at most that unchanged exposure while re-underwriting six non-substitutable gates. [judgment.transdigm.cutoff.defer-reunderwrite; judgment.transdigm.cutoff.six-gates]
  • Strongest favorable evidence: TransDigm estimated that about 90% of FY2014 sales were proprietary, about three-quarters were sole-source and about 55% were aftermarket. It also reported FY2014 net sales of USD 2,372.906 million, operating income of USD 927.820 million and operating cash flow of USD 541.222 million. The mix is an issuer estimate; the financial coordinates are reported facts. [claim.transdigm.cutoff.proprietary-aftermarket-model; table.transdigm.cutoff.annual-results; table.transdigm.cutoff.cash-debt]
  • Why that is insufficient: issuer-defined acquisition sales represented 65.216519% of the FY2014 reported sales increase and 76.941781% of the Q1 FY2015 increase, while the cutoff record does not reconcile acquisition-cohort cash returns. Reported debt increased USD 1,741.893 million in FY2014, and Q1 interest expense was 16.857273% of sales. These are descriptive scale checks—not acquisition return, leverage, interest coverage or valuation. [claim.transdigm.cutoff.acquisition-return-gap; table.transdigm.cutoff.deterministic-checks; model-run.transdigm.cutoff-serial-acquirer-checks]
  • Abstention: do not calculate price attractiveness, intrinsic value, a target price, position size, acquisition IRR or trade instructions. Cutoff-valid capitalization, market price, cohort cash flows, downside funding, governance, mandate and approval inputs are incomplete. [claim.transdigm.cutoff.valuation-not-ready; judgment.transdigm.cutoff.valuation-abstention]

This outcome-blind learner packet admits only evidence public by 2015-02-25T23:59:59Z and asks for a decision at 2015-02-26T14:30:00Z. It does not infer later events from missing cutoff evidence.

Decision frame

The committee cannot undo the already-signed Telair agreement. Its live choices are to initiate or add now, maintain a hypothetical position without gates, defer and re-underwrite while leaving at most a human-approved existing exposure unchanged, or ask an authorized human to reduce or avoid exposure. The selected alternative authorizes no external action. [claim.transdigm.cutoff.telair-signed-not-closed; judgment.transdigm.cutoff.defer-reunderwrite]

The evidence base combines TransDigm's FY2014 10-K and Q1 FY2015 10-Q, an issuer financing and dividend release, contemporaneous independent reporting, and AAR's seller-filed Telair current report. Issuer strategy, mix, liquidity and capacity statements remain claims; filed line items and signed terms remain facts. source · transdigm.cutoff.fy2014-10k source · transdigm.cutoff.q1-2015-10q source · transdigm.cutoff.dividend-release source · transdigm.cutoff.fool-2015 source · transdigm.cutoff.telair-aar-8k

What is established at the cutoff

TransDigm described a portfolio in which it estimated roughly 90% of FY2014 sales were proprietary, roughly 75% were sole-source and roughly 55% were aftermarket, with aircraft-related product lives that could extend for decades. Those statements support a differentiated installed-base hypothesis but do not establish product-level necessity, switching cost, retention, remaining platform life, customer surplus or future cash flow. [claim.transdigm.cutoff.proprietary-aftermarket-model; evidence.transdigm.cutoff.business-model]

FY2014 revenue increased from USD 1,924.400 million to USD 2,372.906 million. Gross profit was USD 1,267.874 million, operating income USD 927.820 million, interest expense USD 347.688 million and net income USD 306.910 million. The deterministic calculations yield 23.306277% reported revenue growth, 53.431278% gross margin and 39.100580% operating margin. [table.transdigm.cutoff.annual-results; table.transdigm.cutoff.deterministic-checks; evidence.transdigm.cutoff.fy2014-income]

Q1 FY2015 revenue was USD 586.898 million, compared with USD 529.322 million a year earlier. Gross profit was USD 321.173 million, operating income USD 240.668 million, interest expense USD 98.935 million and net income USD 95.533 million. The resulting 10.877311% revenue growth and 41.006785% operating margin are reported-value checks, not forecasts. [table.transdigm.cutoff.q1-results; table.transdigm.cutoff.deterministic-checks; evidence.transdigm.cutoff.q1-income]

Management's filed bridges classified USD 292.5 million of FY2014 sales and USD 44.3 million of Q1 FY2015 sales as acquisition sales. The first-quarter filing also described acquisition-sales gross profit at about 32%, below the consolidated 54.723819% gross margin. The classifications show growth mix; they do not supply purchase price, integration, reinvestment or realized cash return by cohort. [claim.transdigm.cutoff.acquisition-led-growth; claim.transdigm.cutoff.acquisition-return-gap; table.transdigm.cutoff.sales-bridge; evidence.transdigm.cutoff.q1-acquisition-gross-profit]

At December 27, 2014, reported cash was USD 1,011.629 million and the named current debt, receivables-securitization borrowing and long-term debt components totaled USD 7,473.131 million. Their arithmetic difference is USD 6,461.502 million, but that is not unconditional net debt or available liquidity. FY2014 operating cash flow less gross capital expenditures was USD 507.076 million; Q1 FY2015 was USD 180.821 million. Both are explicitly scale checks, not free cash flow. [table.transdigm.cutoff.cash-debt; table.transdigm.cutoff.deterministic-checks; evidence.transdigm.cutoff.fy2014-balance-cashflow; evidence.transdigm.cutoff.q1-balance-sheet; evidence.transdigm.cutoff.q1-cash-flow]

The issuer reported an approximately USD 825 million incremental term loan, USD 2.350 billion of notes and a USD 25 special dividend per common share in June 2014. AAR later filed a signed agreement for an aggregate USD 725 million Telair purchase price, plus assumed liabilities and adjustments, subject to closing conditions. Signing does not establish closing, funding, integration, synergy or return. [claim.transdigm.cutoff.debt-distribution-scale; claim.transdigm.cutoff.telair-signed-not-closed; table.transdigm.cutoff.financing-transaction; evidence.transdigm.cutoff.dividend-financing; evidence.transdigm.cutoff.telair-conditions]

A contemporaneous independent article similarly framed most first-quarter growth as acquisition-driven and connected higher interest expense with borrowing used for the special dividend. That is useful outside skepticism, but not audited causality or a calibrated downside probability. [claim.transdigm.cutoff.independent-warning; evidence.transdigm.cutoff.independent-growth-interest]

Six underwriting gates

1. Product necessity, switching and lifecycle

Proprietary, sole-source and aftermarket estimates are favorable evidence only if products solve necessary problems through a durable installed base. The gate is a product-by-platform ledger of source status, qualification alternatives, units, price, mix, retention, remaining lifecycle, required engineering and after-tax cash contribution. No increase is justified while a material cohort residual is unexplained. [claim.transdigm.cutoff.proprietary-aftermarket-model; assumption.transdigm.cutoff.installed-base-durability; table.transdigm.cutoff.gate-gaps]

2. Organic commercial engine

Reported growth and the issuer's organic-sales labels do not isolate price, volume, mix, new business, retention, foreign exchange or classification changes. The gate is a stable bridge from filed revenue and operating cash flow through those drivers, acquisitions, disposals and required product investment, tied without a material unexplained residual. [claim.transdigm.cutoff.acquisition-led-growth; conflict.transdigm.cutoff.growth-versus-cohort-return; table.transdigm.cutoff.sales-bridge]

3. Acquisition diligence, integration and reinvestment

The filing describes targeting proprietary, niche businesses and using EBITDA As Defined in acquisition evaluation. The signed Telair price was 71.666589% of Q1 reported cash and 133.956122% of FY2014 operating cash flow. Those cross-period ratios show transaction scale only; they say nothing about funding sufficiency or return. [evidence.transdigm.cutoff.acquisition-method; table.transdigm.cutoff.deterministic-checks; claim.transdigm.cutoff.telair-signed-not-closed]

The gate is a cohort schedule reconciling purchase price, financing, purchase accounting, integration cost, organic operating performance, necessary engineering and commercial investment, taxes, working capital and realized cash return. The cohort must clear an approved fully loaded return threshold on stable definitions. [claim.transdigm.cutoff.acquisition-return-gap; assumption.transdigm.cutoff.acquisition-integration; table.transdigm.cutoff.gate-gaps]

4. GAAP, adjusted measures and earnings-to-cash

The filed GAAP line items support reproducible reconstruction. TransDigm explicitly called EBITDA and EBITDA As Defined non-GAAP and connected the latter with acquisition evaluation and some covenant analysis. Neither adjusted measure is interchangeable with GAAP earnings, operating cash flow, debt service or cohort return. [claim.transdigm.cutoff.gaap-adjusted-boundary; evidence.transdigm.cutoff.non-gaap-boundary]

The gate requires a stable bridge from GAAP through every adjustment, purchase-accounting effect, tax, working-capital movement, capital expenditure, integration use and other recurring cash need. A material unreconciled adjustment or cash use blocks an increase and a material reporting or control exception triggers human reduction review. [judgment.transdigm.cutoff.six-gates; table.transdigm.cutoff.gate-gaps]

5. Debt, interest, liquidity, covenants and refinancing

Management said cash, an undrawn revolver, additional facility capacity and cash generation should provide adequate capacity. That company claim predated the Telair signing and does not replace an instrument-level downside schedule. Operating cash flow is opposing evidence to leverage risk; neither proves the other away. [claim.transdigm.cutoff.issuer-capacity; conflict.transdigm.cutoff.cash-generation-versus-leverage]

Treasury must reconcile accessible cash, rates, maturities, collateral, covenants, hedges, commitments, distributions, Telair sources and uses, integration needs and stressed operating cash flow. Breach of approved minimum-cash or covenant-headroom buffers routes reduction before further commitment; two consecutive funding-path misses force re-underwriting. [assumption.transdigm.cutoff.funding-resilience; table.transdigm.cutoff.gate-gaps]

6. Governance, customer harm, regulatory exposure and valuation readiness

The FY2014 filing disclosed that the U.S. Government could review fair-and-reasonable pricing and seek refunds, cost-based pricing or alternative sources. That does not prove misconduct or customer harm. It does show that proprietary positioning cannot substitute for contract-level evidence of value delivered, customer alternatives, complaints, quality, regulatory review and board remediation. [claim.transdigm.cutoff.governance-pricing-risk; conflict.transdigm.cutoff.moat-versus-customer-harm; evidence.transdigm.cutoff.government-pricing-risk]

A material unresolved pricing, customer-harm, quality, regulatory or control conflict triggers human reduction review. Valuation remains separate and blocked until cutoff market price, diluted capitalization, approved operating forecast, mandate, current exposure, risk budget and human approvals are complete. [assumption.transdigm.cutoff.governance-controls; claim.transdigm.cutoff.valuation-not-ready; judgment.transdigm.cutoff.valuation-abstention]

Alternatives and scenario frame

AlternativeCutoff supportPrincipal objection
Initiate or add nowDifferentiated installed-base claims, GAAP profitability, operating cash flow and a stated acquisition methodProduct cohorts, fully loaded acquisition returns, downside funding, governance and valuation are unresolved
Maintain without gatesAvoids immediate portfolio turnover while operations remain profitableCurrent exposure and mandate are unknown; unconditional maintenance suppresses decision-critical evidence gaps
Defer and re-underwritePreserves information value and leaves at most a human-approved existing exposure unchangedAny retained exposure still bears leverage, integration, pricing and lifecycle risk
Human-directed reductionProtects against downside that the packet cannot yet boundFavorable proprietary-position, profitability and cash-generation evidence remains material

The outcome-blind scenario weights are 30% for all six gates clearing, 45% for mixed compounding and funding resilience, and 25% for operating, funding or governance impairment. They are subjective decision branches—not empirical base rates, expected returns or valuation probabilities. The linked deterministic run describes cutoff arithmetic only and does not forecast a branch or price the security. [assumption.transdigm.cutoff.scenario-weights; model-run.transdigm.cutoff-serial-acquirer-checks]

Recommendation, monitoring and kill rules

Initiate or add no capital and authorize no execution. If a human-approved, mandate-compliant position already exists, maintain at most that unchanged exposure with moderate confidence while re-underwriting. Consider an increase only when all six gates have documentary lineage and a deterministic, human-approved valuation clears an approved margin of safety. [judgment.transdigm.cutoff.defer-reunderwrite; judgment.transdigm.cutoff.six-gates; judgment.transdigm.cutoff.valuation-abstention]

Monitor six governed records:

  1. Product necessity, source status, switching, lifecycle and after-tax cash economics, quarterly and before material acquisitions.
  2. A GAAP-tied organic revenue and cash-flow bridge, quarterly.
  3. Acquisition-cohort integration, reinvestment and after-tax return, monthly during integration and quarterly thereafter.
  4. GAAP-to-adjusted and earnings-to-cash reconciliations, at every filing and before any adjusted measure is used.
  5. Executed debt, accessible cash and covenant headroom, monthly and at financing, distribution or acquisition events.
  6. Customer, quality, regulatory and board-control evidence plus valuation readiness, monthly with immediate material-event escalation.

Immediate escalation or kill rules are a material unresolved reporting or internal-control exception; a breached approved minimum-cash or covenant-headroom buffer; two consecutive material integration, cohort-return or funding-path misses; or a material unresolved pricing, customer-harm, quality or regulatory conflict. The packet sends any reduction or external action to an authorized human.

Further questions before committing capital

  • Which product and platform cohorts remain necessary and sole-source after qualification alternatives, lifecycle and switching behavior are verified?
  • Can acquisitions, disposals, price, volume, mix, new business, retention and foreign exchange reconcile exactly to GAAP revenue and operating cash flow?
  • What realized acquisition-cohort cash returns remain after purchase price, financing, purchase accounting, integration, taxes, working capital and required reinvestment?
  • Which EBITDA As Defined adjustments recur in cash, and how do purchase-accounting effects reconcile to cohort economics?
  • What executed debt terms, maturities, collateral, covenants, hedges and stressed liquidity remain after distributions and Telair funding?
  • What contract-level customer value, alternatives, complaints, quality, government-pricing review and remediation evidence would falsify the favorable thesis?
  • What verified cutoff capitalization, forecast, mandate and risk budget would permit deterministic valuation and an approved position size?

Caveats

The calculation run is deterministic and source-lined but non-authoritative because no frozen model-registry execution receipt exists. Its OCF-minus-capital-expenditure figures are scale checks rather than free cash flow, and its Telair ratios are neither funding-capacity nor return measures. [model-run.transdigm.cutoff-serial-acquirer-checks; table.transdigm.cutoff.deterministic-checks]

The issuer dividend release was admitted at conservative UTC day-end from its displayed 2014 date; the currently retrieved page also carries a later modification timestamp. The packet uses it for disclosed financing and dividend terms while preserving that archival limitation. source · transdigm.cutoff.dividend-release

Facts, company claims, assumptions, conflicts, unknowns and analyst judgments remain distinct. Missing cutoff evidence lowers underwriting readiness; it does not become proof of customer harm, wrongdoing, regulatory action, investment loss or any later outcome.

As reported at the cutoff

Financial and operating evidence

7 tables

Values are carried from the checked research packet with their original units, periods, scope, and reporting status. “Not established” is preserved rather than estimated.

FY2013 and FY2014 consolidated reported resultsAs Reported At Cutoff · USDm
MeasureFY2013FY2014
Net sales1,924.412,372.9061
Gross profit1,049.56211,267.8741
Income from operations749.4551927.821
Interest expense net270.6851347.6881
Net income302.7891306.911
USD · USDmReported values remain strings; no browser-side recalculation.
Q1 FY2014 and Q1 FY2015 consolidated reported resultsAs Reported At Cutoff · USDm
MeasureQ1 FY2014Q1 FY2015
Net sales529.3221586.8981
Gross profit284.1361321.1731
Income from operations210.6261240.6681
Interest expense net80.853198.9351
Net income86.123195.5331
USD · USDmReported values remain strings; no browser-side recalculation.
Issuer-defined organic and acquisition sales bridgesAs Reported At Cutoff · USDm
MeasureFY2014Q1 FY2015
Issuer-defined organic sales2,080.41542.61
Issuer-defined acquisition sales292.5144.31
USD · USDmReported values remain strings; no browser-side recalculation.
Reported cash debt and cash-flow coordinatesAnalyst Normalized · mixed
MeasureFY2013 or Sept. 30 2013FY2014 or Sept. 30 2014Q1 FY2015 or Dec. 27 2014
Cash and cash equivalents USDm564.741819.54811,011.6291
Named stated debt USDm5,731.23817,473.13117,473.1311derived
Operating cash flow USDmNot established541.2221188.9591
Gross capital expenditures USDm positive cash useNot established34.14618.1381
USD · mixedReported values remain strings; no browser-side recalculation.
Financing distribution and signed Telair terms kept separateAs Reported At Cutoff · mixed
MeasureNamed cutoff-valid event
Incremental term loan USDm approximate8251
Senior subordinated notes offering USDm2,3501
Special dividend USD per common share251
Signed Telair aggregate price USDm before adjustments and assumed liabilities7251
USD · mixedReported values remain strings; no browser-side recalculation.
Deterministic cutoff operating acquisition and funding scale checksAnalyst Normalized · mixed
MeasureCutoff-valid deterministic check
FY2014 revenue growth percent23.3061derived
FY2014 acquisition sales share of reported sales increase percent65.2171derived
FY2014 gross margin percent53.4311derived
FY2014 operating margin percent39.1011derived
FY2014 interest expense to revenue percent14.6521derived
FY2014 stated debt increase USDm1,741.8931derived
FY2014 OCF after gross capex USDm not FCF507.0761derived
Q1 FY2015 revenue growth percent10.8771derived
Q1 FY2015 acquisition sales share of reported sales increase percent76.9421derived
Q1 FY2015 gross margin percent54.7241derived
Q1 FY2015 operating margin percent41.0071derived
Q1 FY2015 interest expense to revenue percent16.8571derived
Q1 stated debt USDm7,473.1311derived
Q1 stated debt less cash scale USDm6,461.5021derived
Q1 FY2015 OCF after gross capex USDm not FCF180.8211derived
Signed Telair price to Q1 cash percent scale only71.66712derived
Signed Telair price to FY2014 OCF percent scale only133.95612derived
USD · mixedReported values remain strings; no browser-side recalculation.
Six decision-critical gates incomplete at the cutoffAnalyst Normalized · mixed
MeasureAt Feb. 25 2015 cutoff
Product necessity switching and lifecycle evidenceNot established
Organic price volume mix new-business and retention bridgeNot established
Acquisition-cohort integration reinvestment and cash returnNot established
GAAP adjusted purchase-accounting and cash-conversion bridgeNot established
Complete downside debt covenant refinancing and liquidity scheduleNot established
Customer-harm regulatory and valuation readinessNot established
mixedReported values remain strings; no browser-side recalculation.

Lineage

Sources available at the cutoff

5 records

Only these records were permitted inside the outcome-blind packet. Links lead to the publisher or filing archive; raw retrieved documents and excerpts are not republished here.

T1

src.transdigm.cutoff.fy2014-10k

d789382d10k.htm

U.S. Securities and Exchange Commission · Nov 14, 2014

Regulatory FilingPrimaryContemporaneous

Used for: Audited financial reconstruction · Business model and acquisition-policy disclosure · Non-GAAP and government-pricing risk boundaries

T1

src.transdigm.cutoff.q1-2015-10q

d834606d10q.htm

U.S. Securities and Exchange Commission · Jan 30, 2015

Regulatory FilingPrimaryContemporaneous

Used for: Latest cutoff financial reconstruction · Organic and acquisition-sales bridge · Cash-flow, debt and interest scale

T1

src.transdigm.cutoff.telair-aar-8k

a15-5228_18k.htm

U.S. Securities and Exchange Commission · Feb 24, 2015

Regulatory FilingPrimaryContemporaneous

Used for: Signed Telair purchase agreement and announced price · Closing-condition boundary

Decision recorded?

Now test it against the outcome.

Reveal Part B